PolitMaster.com is a comprehensive online platform providing insightful coverage of the political arena: International Relations, Domestic Policies, Economic Developments, Electoral Processes, and Legislative Updates. With expert analysis, live updates, and in-depth features, we bring you closer to the heart of politics. Exclusive interviews, up-to-date photos, and video content, alongside breaking news, keep you informed around the clock. Stay engaged with the world of politics 24/7.
BATON ROUGE, La. (AP) — Two abortion-inducing drugs could soon be reclassified as controlled and dangerous substances in Louisiana under a first-of-its-kind bill that received final legislative passage Thursday and is expected to be signed into law by the governor.
When the U.S. Supreme Court issued its unanimous decision in Alliance v. FDA last week, it handed down a little victory for reproductive freedom by tossing a suit brought by far-right extremists who hoped to entirely block federal approval of mifepristone.
The Supreme Court will hear oral arguments Tuesday over access to mifepristone, a medication commonly used to induce abortions, in a case that has major implications for abortion access across the United States.
What to know about today's hearingThe Supreme Court is hearing a challenge to the Food and Drug Administration's decisions over the past several years to increase access to mifepristone, a drug used in medication abortions, including making it available by mail.A Texas-based U.S. district judge invalidated the FDA's approval of the pill last year, but an appeals court narrowed the decision to include only actions the agency took since 2016. Because the Supreme Court is not reviewing the FDA's initial approval of the drug, it will remain available in some form. Fourteen states completely ban abortion, including medication abortion, according to the Guttmacher Institute, while several others prohibit delivering the abortion pill by mail and require patients to see a doctor in person before they can get a prescription for it. About two-thirds of abortions in the United States were carried about by use of the pill in 2023, the research group says.
The future of access to abortion pills may turn on a basic legal question: Who has a right to bring a lawsuit?
The Supreme Court is expected on Tuesday to weigh the availability of a commonly used abortion pill, raising the possibility that it could sharply curtail access to the drug — even in states where abortion access remains legal.
The U.S. Supreme Court will take up a case Tuesday that could impact how women get access to mifepristone, one of the two pills used in the most common type of abortion in the nation.
WASHINGTON — Vaccines, birth control pills, hormone therapies and fertility drugs would be subject to new litigation if the Supreme Court endorses a challenge to abortion pill mifepristone, pharmaceutical industry experts warn.